This is a competing renewal application of a training grant currently in its 30th year of funding. The overall goal of this proposal is to train postdoctoral M.D. and Ph.D. fellows for academic careers in investigational dermatology. Its first objective is to provide laboratory training for dermatologically-trained physicians. Its second objective is to train Ph.D. basic scientists in laboratory-based investigative dermatology. Its third objective is to train dermatologists in clinical and translational research. Trainees will commit to a minimum of two years of research training, which will occur under the supervision of one of eleven primary preceptors. Laboratory-based fellows (M.D. and Ph.D.) will learn to formulate hypotheses and to design, perform, and analyze experiments, utilizing a multidisciplinary approach that emphasizes the use of human skin tissue as an experimental system. M.D. trainees in clinical/translational research will acquire proficiency in hypothesis-driven clinical research design and methods and in statistical analysis of data, while gaining an appreciation of the basic science knowledge underlying their clinical observations and interventions. To maximize multidisciplinary training, and to broaden our outreach into the broader University community, we have added three highly qualified primary preceptors from outside the Department of Dermatology. In addition to mandatory participation in selected departmental didactic activities, introductory and advanced courses in clinical research methods and a molecular biology course for clinician-scientists will be available for trainees through the Medical School and the School of Public Health. Also, training in the responsible conduct of research will be provided at the departmental and University-wide levels. In order to attract more dermatologists into academic careers, we have (i) incorporated two-year fellowships in cutaneous oncology and appearance-based dermatology, (ii) expanded our training opportunities to those interested in dermatopathology, and (iii) expanded our traditional clinical research base in skin pharmacology to encompass a wider spectrum of interventions, notably those involving ultraviolet light. We have also changed our resident selection procedure in order to identify and attract NRSA-eligible M.D.s with strong research potential, with excellent results. Finally, we have created a Web site for dissemination of detailed information about our program to all potential trainees, including those belonging to underrepresented minorities. By training M.D.s and Ph.D.s in state-of-the-art dermatological research at both the basic and clinical / translational levels, we will maximize the clinical impact of research, enhance the abilities of our trainees to teach future physicians, and increase the basic knowledge upon which our specialty increasingly depends.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32AR007197-35
Application #
8268924
Study Section
Arthritis and Musculoskeletal and Skin Diseases Special Grants Review Committee (AMS)
Program Officer
Cibotti, Ricardo
Project Start
1977-07-01
Project End
2014-04-30
Budget Start
2012-05-01
Budget End
2014-04-30
Support Year
35
Fiscal Year
2012
Total Cost
$128,422
Indirect Cost
$12,808
Name
University of Michigan Ann Arbor
Department
Dermatology
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Tsoi, Lam C; Yang, Jingjing; Liang, Yun et al. (2018) Transcriptional determinants of individualized inflammatory responses at anatomically separate sites. J Allergy Clin Immunol 141:805-808
Cole, Megan A; Quan, Taihao; Voorhees, John J et al. (2018) Extracellular matrix regulation of fibroblast function: redefining our perspective on skin aging. J Cell Commun Signal 12:35-43
Swindell, William R; Beamer, Maria A; Sarkar, Mrinal K et al. (2018) RNA-Seq Analysis of IL-1B and IL-36 Responses in Epidermal Keratinocytes Identifies a Shared MyD88-Dependent Gene Signature. Front Immunol 9:80
Furnholm, Teal; Rehan, Medhat; Wishart, Jessica et al. (2017) Pb2+ tolerance by Frankia sp. strain EAN1pec involves surface-binding. Microbiology 163:472-487
Sarkar, Mrinal K; Kaplan, Nihal; Tsoi, Lam C et al. (2017) Endogenous Glucocorticoid Deficiency in Psoriasis Promotes Inflammation and Abnormal Differentiation. J Invest Dermatol 137:1474-1483
Liang, Yun; Tsoi, Lam C; Xing, Xianying et al. (2017) A gene network regulated by the transcription factor VGLL3 as a promoter of sex-biased autoimmune diseases. Nat Immunol 18:152-160
Swindell, William R; Sarkar, Mrinal K; Liang, Yun et al. (2017) RNA-seq identifies a diminished differentiation gene signature in primary monolayer keratinocytes grown from lesional and uninvolved psoriatic skin. Sci Rep 7:18045
Klein, Rachel Herndon; Lin, Ziguang; Hopkin, Amelia Soto et al. (2017) GRHL3 binding and enhancers rearrange as epidermal keratinocytes transition between functional states. PLoS Genet 13:e1006745
Worthen, Christal A; RittiƩ, Laure; Fisher, Gary J (2017) Mechanical Deformation of Cultured Cells with Hydrogels. Methods Mol Biol 1627:245-251
Swindell, William R; Michaels, Kellie A; Sutter, Andrew J et al. (2017) Imiquimod has strain-dependent effects in mice and does not uniquely model human psoriasis. Genome Med 9:24

Showing the most recent 10 out of 54 publications